Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Clinical Outcome
4 results:

  • 1. Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?
    Iacopetta B; Kawakami K; Watanabe T
    Int J Clin Oncol; 2008 Dec; 13(6):498-503. PubMed ID: 19093176
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Changes in mcl-1 expression in rectal cancer in relation to neo-adjuvant radiotherapy.
    Ulrich-Pur H; Erovic BM; Soleiman A; Jech B; Pennwieser W; Czembirek C; Zielinski CC; Thurnher D
    Wien Klin Wochenschr; 2005 Feb; 117(4):136-40. PubMed ID: 15847193
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer.
    Backus HH; van Riel JM; van Groeningen CJ; Vos W; Dukers DF; Bloemena E; Wouters D; Pinedo HM; Peters GJ
    Ann Oncol; 2001 Jun; 12(6):779-85. PubMed ID: 11484952
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma.
    Rayson D; Bouttell E; Whiston F; Stitt L
    J Surg Oncol; 2000 Nov; 75(3):186-92. PubMed ID: 11088050
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.